Play

Maddie Whalen, Evidence-Based Practice Program Coordinator for the Center for Nursing Inquiry joins Heather Watson, Johns Hopkins Health System Nurse Scientist to cover the Appendix E tools: E1, E2, E3.  Appendix E includes appraisal templates for a variety of evidence …

Episode 68: Appendix E – 5th Edition (Part 6) | Johns Hopkins Center for Nursing Inquiry Read more »

Play

We’re up to part 5 in our series – Appendix D, or the Appraisal Tool Selection Algorithm. Kim Bissett, EBP Coordinator for the Institute for Johns Hopkins Nursing is back to explain to Heather Watson, Nurse Scientist for the Johns …

Episode 67: Appendix D – 5th Edition (Part 5)  | Johns Hopkins Center for Nursing Inquiry Read more »

Play

Hot flashes and night sweats are called vasomotor symptoms, and they’re experienced by many women approaching menopause and those being treated for certain breast cancers. Now a new class of drugs has been developed to help. William Nelson, director of …

Can hot flashes and night sweats be controlled in women having treatment for breast cancer? Elizabeth Tracey reports Read more »

Play

Women whose breast cancer has estrogen receptors are usually treated with estrogen depleting medicines, with the consequence that they have hot flashes and night sweats, so called ‘vasomotor symptoms,’ that many describe as worse than menopause. Now a new medicine …

There’s hope for women with breast cancer who are experiencing menopausal symptoms, Elizabeth Tracey reports Read more »

Play

CAR-T cells, a highly activated immune cell, have been used to treat a solid tumor, stomach cancer, for the first time. Yet the fact remains that CAR-Ts are expensive and time consuming to produce. Johns Hopkins Kimmel Cancer Center director …

CAR-T cells are an expensive form of cancer treatment, but other techniques may soon supplant them, Elizabeth Tracey reports Read more »

Play

For the first time CAR-T cells, a highly activated type of immune cell, have been used with some success to treat stomach cancer, a so-called solid tumor. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says solid …

Why has it been so hard to use CAR-T cells to treat solid tumors? Elizabeth Tracey reports Read more »

Play

You’ve probably heard of CAR-T cells, a type of immune cells taken from someone’s body, grown up in a lab and trained to attack their cancer. CAR-Ts are known to be good for treating blood cancers like leukemia, and for …

Will solid tumors now be treated with CAR-T cells? Elizabeth Tracey reports Read more »